357 related articles for article (PubMed ID: 29957236)
1. The Role of Nutraceuticals in Statin Intolerant Patients.
Banach M; Patti AM; Giglio RV; Cicero AFG; Atanasov AG; Bajraktari G; Bruckert E; Descamps O; Djuric DM; Ezhov M; Fras Z; von Haehling S; Katsiki N; Langlois M; Latkovskis G; Mancini GBJ; Mikhailidis DP; Mitchenko O; Moriarty PM; Muntner P; Nikolic D; Panagiotakos DB; Paragh G; Paulweber B; Pella D; Pitsavos C; Reiner Ž; Rosano GMC; Rosenson RS; Rysz J; Sahebkar A; Serban MC; Vinereanu D; Vrablík M; Watts GF; Wong ND; Rizzo M;
J Am Coll Cardiol; 2018 Jul; 72(1):96-118. PubMed ID: 29957236
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease.
Marazzi G; Pelliccia F; Campolongo G; Quattrino S; Cacciotti L; Volterrani M; Gaudio C; Rosano G
Am J Cardiol; 2015 Dec; 116(12):1798-801. PubMed ID: 26611120
[TBL] [Abstract][Full Text] [Related]
3. Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia.
Patti AM; Toth PP; Giglio RV; Banach M; Noto M; Nikolic D; Montalto G; Rizzo M
Curr Pharm Des; 2017; 23(17):2496-2503. PubMed ID: 28317482
[TBL] [Abstract][Full Text] [Related]
4. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.
Cicero AFG; Colletti A; Bajraktari G; Descamps O; Djuric DM; Ezhov M; Fras Z; Katsiki N; Langlois M; Latkovskis G; Panagiotakos DB; Paragh G; Mikhailidis DP; Mitchenko O; Paulweber B; Pella D; Pitsavos C; Reiner Ž; Ray KK; Rizzo M; Sahebkar A; Serban MC; Sperling LS; Toth PP; Vinereanu D; Vrablík M; Wong ND; Banach M
Nutr Rev; 2017 Sep; 75(9):731-767. PubMed ID: 28938795
[TBL] [Abstract][Full Text] [Related]
5. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Cicero AFG; Fogacci F; Stoian AP; Vrablik M; Al Rasadi K; Banach M; Toth PP; Rizzo M
Curr Atheroscler Rep; 2021 Aug; 23(10):57. PubMed ID: 34345932
[TBL] [Abstract][Full Text] [Related]
6. The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.
Penson PE; Banach M
Curr Atheroscler Rep; 2020 Sep; 22(11):67. PubMed ID: 32945980
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis.
Morze J; Osadnik T; Osadnik K; Lejawa M; Jakubiak G; Pawlas N; Gasior M; Schwingshackl L; Banach M
BMJ Open; 2020 Aug; 10(8):e032755. PubMed ID: 32819924
[TBL] [Abstract][Full Text] [Related]
8. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.
Osadnik T; Goławski M; Lewandowski P; Morze J; Osadnik K; Pawlas N; Lejawa M; Jakubiak GK; Mazur A; Schwingschackl L; Gąsior M; Banach M
Pharmacol Res; 2022 Sep; 183():106402. PubMed ID: 35988871
[TBL] [Abstract][Full Text] [Related]
9. Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias.
Scognamiglio M; Costa D; Sorriento A; Napoli C
Curr Pharm Des; 2019; 25(1):85-95. PubMed ID: 30706799
[TBL] [Abstract][Full Text] [Related]
10. Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance.
Koskinas K; Wilhelm M; Windecker S
Swiss Med Wkly; 2016; 146():w14333. PubMed ID: 27400448
[TBL] [Abstract][Full Text] [Related]
11. A Clinical Guide to Combination Lipid-Lowering Therapy.
Russell C; Sheth S; Jacoby D
Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190
[TBL] [Abstract][Full Text] [Related]
12. Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
Cicero AF; Colletti A
Phytomedicine; 2016 Oct; 23(11):1113-8. PubMed ID: 26621556
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial).
Marazzi G; Campolongo G; Pelliccia F; Quattrino S; Vitale C; Cacciotti L; Massaro R; Volterrani M; Rosano G
Am J Cardiol; 2017 Sep; 120(6):893-897. PubMed ID: 28781026
[TBL] [Abstract][Full Text] [Related]
14. Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.
Stefanutti C; Mazza F; Mesce D; Morozzi C; Di Giacomo S; Vitale M; Pergolini M
Atheroscler Suppl; 2017 Nov; 30():86-91. PubMed ID: 29096866
[TBL] [Abstract][Full Text] [Related]
15. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
[TBL] [Abstract][Full Text] [Related]
16. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
[TBL] [Abstract][Full Text] [Related]
17. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
Ahmed MH; Al-Atta A; Hamad MA
Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of Nutraceuticals with Lipid Lowering Properties.
Poli A; Visioli F
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):113-118. PubMed ID: 30877602
[TBL] [Abstract][Full Text] [Related]
19. Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factors.
Arnaboldi L; Corsini A; Bellosta S
Minerva Med; 2022 Feb; 113(1):141-157. PubMed ID: 35313442
[TBL] [Abstract][Full Text] [Related]
20. Lipids: a personal view of the past decade.
Katsiki N; Mikhailidis DP
Hormones (Athens); 2018 Dec; 17(4):461-478. PubMed ID: 30229482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
